HTA Database - Search Results

Sort by Relevance

Search Results [271 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Augmentative and alternative communication device with eye tracking (TOBII) in language and motor speech disorders
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for relapsing neuromyelitis optica spectrum disorders
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Magnetic resonance imaging with tractography for brain white matter diseases
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016	HAYES, Inc.	Intravenous immunoglobulin for the treatment of myasthenia gravis
2016	HAYES, Inc.	iFuse implant system (SI-Bone Inc.) for sacroiliac joint fusion for treatment of low back pain
2016	HAYES, Inc.	Peristeen anal irrigation system (Coloplast) for bowel management in pediatric populations
2016	HAYES, Inc.	Sacroiliac joint injections with corticosteroids for treatment of chronic low back pain
2016	Adelaide Health Technology Assessment (AHTA)	Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pharmacogenetic test (Neurofarmagen®) to assess the potential response to drugs and adverse effects in patients with neuropsychiatric disorders]
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Neurostimulation system for cluster headache]
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2015	Basque Office for Health Technology Assessment (OSTEBA)	[An evaluation of the efficacy of psychosocial techniques (cognitive rehabilitation vs. psychoeducation) as an additional treatment to pharmacological treatment in bipolar disorder]
2014	HAYES, Inc.	L1 syndrome (L1CAM-related disorders)
2014	HAYES, Inc.	Von Hippel-Lindau (VHL) syndrome
2014	HAYES, Inc.	ATI neurostimulation system (Autonomic Technologies Inc.) for electrical stimulation of the Sphenopalatine Ganglion (SPG) for headache
2014	HAYES, Inc.	HLA-B testing for guidance of treatment with anticonvulsant drugs
2014	HAYES, Inc.	Plasma exchange for treatment of steroid-refractory transverse myelitis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neurofeedback and biofeedback for mood and anxiety disorders: a review of the clinical evidence and guidelines
2014	HAYES, Inc.	Percutaneous tibial nerve stimulation for the treatment of lower urinary tract dysfunction
2014	HAYES, Inc.	Onyx liquid embolic system (Onyx HD-500) (Covidien / ev3 Neurovascular) for treatment of cerebral aneurysms
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014	Canary Health Service	[Systematic review of aCGH for the genetic study of pediatric neurodevelopmental disorders]
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013	HAYES, Inc.	Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	COGNISION™ for neurological disorders, including dementia
2013	HAYES, Inc.	Citrin deficiency
2013	HAYES, Inc.	Cystic Fibrosis Transmembrane Regulator (CFTR) testing for cystic fibrosis
2013	HAYES, Inc.	DNA Polymerase Gamma (POLG)-related disorders
2013	HAYES, Inc.	Ehlers-Danlos Syndrome type IV (EDS IV)
2013	HAYES, Inc.	Genomic microarray analysis for intellectual disability, developmental delay, multiple congenital anomalies, and autism spectrum disorders
2013	HAYES, Inc.	Tai chi for improving balance and function in patients with parkinson's disease
2013	HAYES, Inc.	Use of anti-infliximab antibody levels to monitor infliximab treatment in patients with inflammatory bowel disease (IBD)
2013	HAYES, Inc.	Autosomal Dominant Hereditary Spastic Paraplegia (AD-HSP)
2013	HAYES, Inc.	Autosomal Recessive Hereditary Spastic Paraplegia (AR-HSP)
2013	HAYES, Inc.	Whole exome sequencing for noncancer indications
2013	HAYES, Inc.	Lokomat (Hocoma AG) Driven Gait Orthosis (DGO) for use in children with cerebral palsy
2013	Andalusian Health Technology Assessment Area (AETSA)	[Safety and efficacy of therapeutic hypothermia for acute ischemic stroke. Systematic review and Meta-analysis]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neuromuscular occlusion concept-based diagnosis and treatment of tempromandibular joint disorders: a review of the clinical evidence
2013	HAYES, Inc.	Vagus nerve stimulation for depression
2013	HAYES, Inc.	Phenylalanine hydroxylase (PAH) deficiency (including phenylketonuria [PKU])
2013	HAYES, Inc.	PLP1-related disorders (including pelizaeus-merzbacher disease [PMD])
2013	Haute Autorite de sante (HAS)	[Bone substitutes]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[Results of the perinatal care of very premature children in the health system of the Basque Country]
2013	National Institute for Health and Care Excellence (NICE)	Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal). NICE technology appraisal guidance 277
2013	Canary Health Service	[Deep brain stimulation in neurological and psychiatric disorders]
2013	Canary Health Service	[Indications for transcranial magnetic stimulation: major depressive disorder and other disorders]
2012	NIHR Health Technology Assessment programme	The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
2012	HAYES, Inc.	Forkhead Box Protein G1 (FOXG1) testing in congenital variant of Rett Syndrome
2012	HAYES, Inc.	DaTscan (123I-Ioflupane; GE Healthcare) for diagnosis of Parkinson's Disease
2012	HAYES, Inc.	Spinal cord stimulation for relief of neuropathic pain
2012	HAYES, Inc.	Hydrogen breath test for irritable bowel syndrome
2012	HAYES, Inc.	Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
2012	Health Information and Quality Authority (HIQA)	Health technology assessment of a national deep brain stimulation service in Ireland
2012	HAYES, Inc.	Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy
2012	HAYES, Inc.	Intravenous immunoglobulin for myasthenia gravis
2012	HAYES, Inc.	In utero fetal surgery for myelomeningocele
2012	HAYES, Inc.	Intravenous lidocaine infusion for neuropathic pain
2012	HAYES, Inc.	P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅲ. A study on the current status and treatment promotion of comorbid depression among patients with cancer or patients with diabetes mellitus]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Therapeutic strategies in refractory schizophrenia or treatment resistant schizophrenia]
2011	HAYES, Inc.	Intravenous ketamine for chronic nonmalignant pain
2011	HAYES, Inc.	Near-infrared spectroscopy (INVOS cerebral/somatic oximeter) (Covidien) for adult cerebral indications
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sacral nerve stimulation for the treatment of voiding dysfunction]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Botulinum toxin use in adults and children with urinary tract function disorders]
2011	Adelaide Health Technology Assessment (AHTA)	Brachytherapy for the treatment of prostate cancer
2011	HAYES, Inc.	Noonan syndrome
2011	HAYES, Inc.	Quotient ADHD system (BioBehavioral Diagnostics Company [BioBDx]) for diagnosis of attention-deficit/hyperactivity disorder
2011	HAYES, Inc.	Dentatorubral-Pallidoluysian Atrophy (DRPLA)
2011	HAYES, Inc.	HLA-B*27 testing for ankylosing spondylitis
2011	HAYES, Inc.	Implantable interStim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011	HAYES, Inc.	Friedreich Ataxia (FRDA)
2011	HAYES, Inc.	Generalized Epilepsy with Febrile Seizures Plus (GEFS+)
2011	HAYES, Inc.	Single Nucleotide Polymorphism (SNP) chromosomal microarray analysis for intellectual disability, developmental delay, and/or multiple congenital anomalies
2011	HAYES, Inc.	Tay-Sachs Disease (TSD) testing in individuals of non–ashkenazi jewish origin
2011	HAYES, Inc.	Cecostomy for treatment of fecal incontinence in adults
2011	HAYES, Inc.	Cecostomy for treatment of fecal incontinence in children
2011	HAYES, Inc.	Electrical stimulation of the occipital nerve for treatment of occipital neuralgia
2011	HAYES, Inc.	Functional Electrical Stimulation (FES) for treatment of foot drop in multiple sclerosis patients
2011	HAYES, Inc.	Implantable interstim neurostimulator (Medtronic Inc.) for sacral neuromodulation in treatment of fecal incontinence in adults
2011	HAYES, Inc.	Neuromonics tinnitus treatment (Neuromonics Inc.)
2011	HAYES, Inc.	P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2011	HAYES, Inc.	Remicade (Infliximab; Janssen Biotech Inc., a Johnson&Johnson Company) for treatment of neurosarcoidosis
2011	Institute for Clinical and Economic Review (ICER)	Management options for low back disorders
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Reducing bilirubin-induced neurological dysfunction in premature newborns: additional use of bilirubin:albumin ratio in the treatment of hyperbilirubinemia]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Invasive home mechanical ventilation, mainly focused on neuromuscular disorders]
2010	HAYES, Inc.	Natural Orifice Translumenal Endoscopic Surgery (NOTES) for cholecystectomy
2010	HAYES, Inc.	Neuromonics tinnitus treatment (Neuromonics Inc.)
2010	HAYES, Inc.	Autonomic nervous system monitoring for neuropathy
2010	HAYES, Inc.	Celiac disease
2010	HAYES, Inc.	Early-onset familial Alzheimers disease (EOFAD; AD1, AD3, and AD4 )
2010	HAYES, Inc.	Mitochondrial DNA (mtDNA) whole genome scanning/sequencing
2010	Adelaide Health Technology Assessment (AHTA)	Unattended sleep studies in the diagnosis and reassessment of obstructive sleep apnoea
2010	HAYES, Inc.	Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations
2010	HAYES, Inc.	Intravenous lidocaine infusion for neuropathic pain
2010	HAYES, Inc.	Single-Incision Laparoscopic Surgery (SILS) for cholecystectomy
2010	HAYES, Inc.	SmartPill GI monitoring system (SmartPill Corp.) for diagnosis of gastroparesis and monitoring of intestinal motility
2010	HAYES, Inc.	Use of anti-infliximab antibody levels to monitor infliximab treatment
2010	HAYES, Inc.	APC-Associated Polyposis Conditions